Authorized medicinal products

Medicinal products may only be placed on the market in Liechtenstein if their efficacy and safety have been proven and verified. With one exception, Liechtenstein automatically permits the medicinal products authorized by the Swiss Agency for Therapeutic Products Swissmedic on its market.

List of medicinal products authorized in Switzerland

Exception:

Since 1 June 2005, Swissmedic approvals of medicinal products with new active ingredients are no longer automatically recognized in Liechtenstein. Recognition only takes place with a time delay, usually after 12 months. These medicinal products are included in the NCE negative list (= list of Swiss medicinal products with new active pharmaceutical ingredients that are not authorized in Liechtenstein).

Negative list 2025

Communication on the delayed recognition of Swiss marketing authorizations for medicinal products with new active pharmaceutical ingredients in Liechtenstein

Due to its accession to the EEA, Liechtenstein also accepts medicinal products that have been reviewed and approved by the EU in the central procedure and authorizes them for the Liechtenstein market.

Further specialist information on the centrally authorized medicinal products can be found on the EMA website (European public assessment reports) or on the list of centrally authorized European medicinal products.

The agreement on the automatic recognition of human and veterinary medicinal products authorized or registered in Austria has been in force in Liechtenstein since 1 December 2010. Under the agreement, marketing authorizations for human and veterinary medicinal products are automatically recognized in Liechtenstein by the competent Austrian medicinal products authority if the applicant submits an application to the Austrian medicinal products authority.

Further information on the authorization procedure can be found in the Communication on the Agreement between the Governments of Austria and Liechtenstein on the automatic recognition in Liechtenstein of human and veterinary medicinal products authorized or registered in Austria.

Communication for the pharmaceutical industry

Medicinal products authorized by Austria

The list of medicinal products authorized by Austria and recognized in Liechtenstein and the corresponding technical information can be found here: Recognized medicinal products, authorized by Austria

Communication on the delayed recognition of Swiss authorizations of medicinal products with new active substances in Liechtenstein

Due to its accession to the EEA, Liechtenstein also accepts medicinal products that have been tested and approved by the EU in the central procedure and authorizes them for the Liechtenstein market.

Further specialist information on the centrally authorized medicinal products can be found on the EMA website (European public assessment reports) or on the list of centrally authorized European medicinal products.

The agreement on the automatic recognition of human and veterinary medicinal products authorized or registered in Austria has been in force in Liechtenstein since 1 December 2010. Under the agreement, marketing authorizations for human and veterinary medicinal products are automatically recognized in Liechtenstein by the competent Austrian pharmaceutical authority if the applicant applies to the Austrian pharmaceutical authority.

Further information on the authorization procedure can be found in the Communication on the Agreement between the Governments of Austria and Liechtenstein on the automatic recognition in Liechtenstein of human and veterinary medicinal products authorized or registered in Austria.

Communication for the pharmaceutical industry

Medicinal products authorized by Austria

The list of medicinal products authorized by Austria and recognized in Liechtenstein and the corresponding technical information can be found here: Recognized medicinal products approved by Austria